David Berman
Chief Tech/Sci/R&D Officer bei IMMUNOCORE HOLDINGS PLC
Vermögen: - $ am 31.03.2024
Profil
David Berman is currently the Head of Research & Development at Immunocore Holdings Plc.
Prior to this, he was the Head of Immuno Oncology at Bristol Myers Squibb Co. from 2005 to 2015, the Head of Early Stage Oncology Program at MedImmune LLC from 2015 to 2017, and the Head of Immuno Oncology Franchise at AstraZeneca PLC from 2017 to 2018.
Berman received his undergraduate degree from Massachusetts Institute of Technology and his graduate and doctorate degrees from The University of Texas Southwestern Medical Center.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOCORE HOLDINGS PLC
-.--% | 28.02.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von David Berman
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01.01.2019 |
Ehemalige bekannte Positionen von David Berman
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.01.2018 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01.01.2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2015 |
Ausbildung von David Berman
| Massachusetts Institute of Technology | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
